LAI
GSK icon

Legal Advantage Investments’s GSK GSK Stock Holding History

Legal Advantage Investments’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$322K Hold
6,150
– – 0.11% 72
2026
Q1 		$339K Hold
6,150
– – 0.18% 72
2025
Q4 		$302K Hold
6,150
– – 0.14% 80
2025
Q3 		$265K Buy
+6,150
New +$240K 0.12% 85

Other funds holding GSK

JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return
MIP
Mondrian Investment Partners London, United Kingdom $6.48B AUM 18.36% 1-Year Est. Return
MHI
Miller Howard Investments Kingston, New York $3.77B AUM 23.82% 1-Year Est. Return
DLA
Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return
TNB
Thomasville National Bank Thomasville, Georgia $1.82B AUM
AssetMark Inc
AssetMark Inc Concord, California $58.2B AUM 22.78% 1-Year Est. Return
AA
ABC Arbitrage Paris, France $926M AUM 45.9% 1-Year Est. Return
WF
Welch & Forbes Boston, Massachusetts $8.23B AUM 17.62% 1-Year Est. Return
CFM
Capricorn Fund Managers London, United Kingdom $1.27B AUM 70.17% 1-Year Est. Return
FVWA
Foster Victor Wealth Advisors Greenville, South Carolina $1.9B AUM 24.46% 1-Year Est. Return

Legal Advantage Investments's GSK Position: Q2 2026 in Review

Legal Advantage Investments held its GSK (GSK) position steady in Q2 2026 at 6,150 shares worth $322K. The position accounts for 0.11% of the portfolio, ranked #72.

Legal Advantage Investments first reported a position in GSK in Q3 2025 and has held it in 4 quarters since. The position peaked at $339K in Q1 2026. 439 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

  • Legal Advantage Investments held 6,150 shares of GSK worth $322K as of Q2 2026.
  • Legal Advantage Investments left its GSK share count unchanged in Q2 2026.
  • GSK made up 0.11% of Legal Advantage Investments's portfolio in Q2 2026, its #72 holding.
  • Legal Advantage Investments first reported a position in GSK in Q3 2025 and has held it in 4 quarters since.
  • Legal Advantage Investments's GSK position peaked at $339K in Q1 2026.
  • 439 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Legal Advantage Investments's 13F filing for Q2 2026, filed 15 Jul 2026.